Expand DGX Menu
DGX MENU

DGX Latest Press Releases

-- June 18, 2026 --

UTI-causing Bacteria Resistant to Current Drugs, Finds National Study by Hackensack Meridian CDI and Quest Diagnostics PRNewswire 8:57 AM

-- June 17, 2026 --

Quest Diagnostics to Release Second Quarter Financial Results on July 23, 2026 PRNewswire 9:00 AM

-- June 16, 2026 --

Quest Diagnostics Unveils Achievements in Healthcare Access, Employee Engagement and Environmental Sustainability in 2025 Corporate Responsibility Report PRNewswire 9:01 AM

-- May 19, 2026 --

Quest Diagnostics Declares Quarterly Cash Dividend PRNewswire 4:37 PM

-- April 27, 2026 --

Quest Diagnostics Prices $500 Million of Senior Notes PRNewswire 4:11 PM

-- April 21, 2026 --

Quest Diagnostics Reports First Quarter 2026 Financial Results; Raises Revenue and EPS Guidance for Full Year 2026 PRNewswire 6:47 AM

-- April 16, 2026 --

City of Hope to Evaluate Quest Diagnostics' Haystack MRD for Guiding Patient Management in Multiple Cancers PRNewswire 9:01 AM

-- March 19, 2026 --

Quest Diagnostics to Release First Quarter Financial Results on April 21, 2026 PRNewswire 10:00 AM

-- March 12, 2026 --

Quest Diagnostics Elects Timothy Wentworth, Former CEO of Walgreens Boots Alliance, Evernorth Health Services and Express Scripts, to Board of Directors PRNewswire 4:07 PM

-- March 2, 2026 --

Quest Diagnostics Introduces AI Companion to Help Patients Understand and Act on Lab Test Results PRNewswire 9:02 AM

-- February 26, 2026 --

Quest Diagnostics Names Benjamin Beauvalot Senior Vice President, Chief Strategy and M&A Officer PRNewswire 8:25 AM

-- February 25, 2026 --

Quest Diagnostics to Speak at the Leerink 2026 Global Healthcare Conference PRNewswire 10:00 AM

-- February 10, 2026 --

Quest Diagnostics Reports Fourth Quarter and Full Year 2025 Financial Results; Provides Guidance for Full Year 2026; Increases Quarterly Dividend 7.5% to $0.86 Per Share PRNewswire 6:47 AM
Quest Diagnostics Increases Dividend 7.5% To $0.86 Per Quarter, Marking 15 Consecutive Years of Dividend Increases; Announces $1 Billion Increase in Share Repurchase Authorization PRNewswire 6:33 AM

-- February 2, 2026 --

Quest Diagnostics Launches Novel Flow Cytometry MRD Blood Test for Myeloma, Enabling Ultrasensitive Detection of Residual Disease PRNewswire 8:52 AM

-- January 21, 2026 --

Quest Diagnostics Named to Fortune's World's Most Admired Companies List for 12th Consecutive Year PRNewswire 2:36 PM
Market Data Delayed 15 Minutes